Dr. Goldstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Whitman Walker Health
1525 14th St., NW.
Washington, DC 20005
Summary
- I am a board certified Infectious Disease specialist and spent the past decade practicing HIV care, primary care, and gender-affirming clinical care at Whitman-Walker Health, a Federally Qualified Health Center in Washington DC. For the past five years, as the Director of Clinical Research at WWH, I was the Primary Investigator for 25 phase 1, 2 and 3 HIV and Hepatitis C treatment and prevention studies with over 200 participants, including phase 1 HIV cure study and phase 3 HIV prevention vaccine study.
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Infectious Disease, 2007 - 2009- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2003 - 2006
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003
Amherst CollegeBA, 1994 - 1998
Certifications & Licensure
MD State Medical License 2021 - 2026
DC State Medical License 2005 - 2024
VA State Medical License 2005 - 2022
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Publications & Presentations
PubMed
- 27 citationsResistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.Jeffrey D. Klausner, Claire C. Bristow, Olusegun O. Soge, Akbar Shahkolahi, Toni Waymer
Clinical Infectious Diseases. 2021-07-15 - 149 citationsSafety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trialMartin Markowitz, Ian Frank, Robert M. Grant, Kenneth H. Mayer, Richard Elion
The Lancet. HIV. 2017-08-01 - 3 citationsDespite early Medicaid expansion, decreased durable virologic suppression among publicly insured people with HIV in Washington, DC: a retrospective analysisDeborah Goldstein, W. David Hardy, Anne K Monroe, Qingjiang Hou, Rachel Hart
BMC Public Health. 2020-04-16
Abstracts/Posters
- Trans Females Receiving Gender-Affirming Surgical Referrals are More Likely to Have Durable Virologic Suppression at Whitman-Walker Health, 2008-2017.Deborah Goldstein, Eleanor Sarkodie, David Hardy, IDWeek, Washington, DC, 2019
- Safety and Efficacy of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naïve HIV-1 Infected Adults with Transmitted Non-Nucleoside Rever...Alexander Wong, Deborah Goldstein, Josep Mallolas, Edwin DeJesus, Margaret Johnson, Jean-Michel Molina, Anton Pozniak, Anthony Rodgers, Valerie Teal, Deborah Hepler, S..., HIV Glasgow, 2018
- Week 96 efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in older, HIV-infected treatment-naive adults.Douglas Ward, Melanie Thompson, Deborah Goldstein, Cynthia Brinson, Gordon Crofoot, Clifford Kinder, Hui Wang, Julie Ryu, Ian McNicholl, Richard Haubrich, MD, Amy Wein..., American College of Clinical Pharmacology, 2017
- Join now to see all
Press Mentions
Gender-Affirming Hormone Therapy May Increase Risk of High Blood PressureApril 19th, 2021- Utilization of Direct Oral Anticoagulants in People Living with Human Immunodeficiency Virus: Observational Data from the District of Columbia CohortMarch 17th, 2020
Whitman-Walker seeks volunteers for HIV vaccine study November 5th, 2020
Committees
- PMPC Member, Pharmacy and Medical Policy Committee, BlueCross BlueShield Federal Employees Program 2013 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
